Notice to Readers
Update: Availability of Inactivated Poliovirus Vaccine -- United Sta
The shortage of inactivated poliovirus vaccine (IPV) in the
United States earlier this year (1) has been resolved. On September
28, 1994, the Food and Drug Administration announced the release of
IPV lots manufactured by Pasteur Merieux Serums & Vaccines, S.A. *
(Lyon, France). In addition, IPV (human diploid cell) lots
manufactured by Connaught Laboratories, Limited (Willowdale,
Ontario, Canada), were released on October 5, 1994. The release of
vaccine lots from both manufacturers, distributed by Connaught
Laboratories, Inc. (Swiftwater, Pennsylvania), should quickly
restore normal supplies.
Reference
CDC. Limited supplies of inactivated poliovirus vaccine --
United
States. MMWR 1994;43:595-6.
Use of trade names and commercial sources is for information only
and does not imply endorsement by the Public Health Service or the
U.S. Department of Health and Human Services.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
